SMS Pharmaceuticals Ltd. - Research Center
532815 SMSPHARMA Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 301.98 | 223.82 | 182.17 | 337.70 | 243.02 |
| Operating profit | 54.48 | 13.19 | 22.99 | 91.49 | 45.53 |
| Interest | 11.89 | 10.09 | 9.09 | 9.78 | 5.67 |
| Gross profit | 43.91 | 4.51 | 16.46 | 84.35 | 41.17 |
| EPS (Rs) | 2.52 | -1.07 | 2.31 | 5.73 | 2.41 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 1.32 | 1.41 | 2.56 | 2.64 | 1.31 |
| Stock adjustment | -23.00 | 3.09 | -46.39 | -66.11 | 10.96 |
| Raw material | 194.84 | 148.42 | 140.99 | 246.81 | 144.14 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 27.20 | 25.69 | 27.00 | 24.02 | 18.03 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 48.47 | 33.43 | 37.58 | 41.50 | 24.36 |
| Provisions made | - | - | - | - | - |
| Depreciation | 15.59 | 16.03 | 16.07 | 16.08 | 11.11 |
| Taxation | 6.99 | -2.49 | -19.18 | 19.80 | 9.63 |
| Net profit / loss | 21.33 | -9.02 | 19.57 | 48.47 | 20.43 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 8.47 | 8.47 | 8.47 | 8.47 | 8.47 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.04 | 5.89 | 12.62 | 27.09 | 18.73 |
| GPM (%) | 14.48 | 2.00 | 8.91 | 24.78 | 16.85 |
| NPM (%) | 7.03 | -4.00 | 10.59 | 14.24 | 8.36 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis